Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic

Sponsor
Zeliha Aytekin (Other)
Overall Status
Completed
CT.gov ID
NCT05191407
Collaborator
(none)
301
1
30
305.4

Study Details

Study Description

Brief Summary

Psychological support may be needed to help patients in the face of emotional disturbances that may be associated with the outbreak and to help them accomplish their fear and anxiety. Due to the increasing fear of COVID-19 transmission during the pandemic, patients may develop treatment avoidance behavior in dental practices. If the fear and anxiety levels of the patients can be determined, it may be easy to offer special approaches to them.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Officially, the first COVID-19 case in Turkey was diagnosed on March 10, 2020. To ensure social isolation, cities were locked down with residents to stay at home to prevent disease transmission. A very large part of the population may experience frustration, stress, and irritability while in isolation. Due to the prolonged lockdown and COVID-19 associated fear, the COVID-19 pandemic, which threatens people's physical health and lives, is likely to trigger a wide variety of psychological problems such as anxiety and depression by increasing their stress levels.

    The risk of cross-infection in dentistry has been described as considerably high due to close physical contact between dental professionals and patients, and aerosols production during routine dental treatments. In this uncertain process, patients remain undecided about attending their dental appointments. Their concern is associated with the risk of getting infected and transmitting the disease to family members. All these factors may increase the mental stress of patients.

    The essential purpose of this study is to evaluate the COVID-19 fear and anxiety level, COVID-19 knowledge status, and information sources in dental patients in Turkey during the pandemic period.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    301 participants
    Observational Model:
    Case-Crossover
    Time Perspective:
    Cross-Sectional
    Official Title:
    Investigation of Factors Associated With the Increased Fear and Anxiety in Dental Patients During the COVID-19 Pandemic in Turkey: A Survey
    Actual Study Start Date :
    Sep 23, 2020
    Actual Primary Completion Date :
    Oct 23, 2020
    Actual Study Completion Date :
    Oct 23, 2020

    Outcome Measures

    Primary Outcome Measures

    1. fear of COVID-19 [last six month ( from the beggining of the pandemic to time of survey)]

      The fear of participants is measured by the Turkish validated version of the fear of COVID-19 Scale.

    2. anxiety [last two weeks]

      The anxiety level of the participants is measured by the Turkish version of Generalized Anxiety Disorder-7 Scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • willing to participate with providing informed consent;

    • age ≥18 years

    • able to understand and read & write the Turkish language.

    Exclusion Criteria:
    • not willing to participate with providing informed consent;

    • age<18 years

    • not able to understand and read & write the Turkish language

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Akdeniz University Antalya Turkey 07058

    Sponsors and Collaborators

    • Zeliha Aytekin

    Investigators

    • Study Director: Özlem Daltaban, PhD, Akdeniz University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Zeliha Aytekin, Research Assistant, Akdeniz University
    ClinicalTrials.gov Identifier:
    NCT05191407
    Other Study ID Numbers:
    • 70904504 /706
    First Posted:
    Jan 13, 2022
    Last Update Posted:
    Jan 13, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Zeliha Aytekin, Research Assistant, Akdeniz University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 13, 2022